Literature DB >> 25645841

The Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic molecules.

Olga Danilchanka1, David Pires2, Elsa Anes3, Michael Niederweis4.   

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, is protected from toxic solutes by an effective outer membrane permeability barrier. Recently, we showed that the outer membrane channel protein CpnT is required for efficient nutrient uptake by M. tuberculosis and Mycobacterium bovis BCG. In this study, we found that the cpnT mutant of M. bovis BCG is more resistant than the wild type to a large number of drugs and antibiotics, including rifampin, ethambutol, clarithromycin, tetracycline, and ampicillin, by 8- to 32-fold. Furthermore, the cpnT mutant of M. bovis BCG was 100-fold more resistant to nitric oxide, a major bactericidal agent required to control M. tuberculosis infections in mice. Thus, CpnT constitutes the first outer membrane susceptibility factor in slow-growing mycobacteria. The dual functions of CpnT in uptake of nutrients and mediating susceptibility to toxic molecules are reflected in macrophage infection experiments: while loss of CpnT was detrimental for M. bovis BCG in macrophages that enable bacterial replication, presumably due to inadequate nutrient uptake, it conferred a survival advantage in macrophages that mount a strong bactericidal response. Importantly, the cpnT gene showed a significantly higher density of nonsynonymous mutations in drug-resistant clinical M. tuberculosis strains, indicating that CpnT is under selective pressure in human tuberculosis and/or during chemotherapy. Our results indicate that the CpnT channel constitutes an outer membrane gateway controlling the influx of nutrients and toxic molecules into slow-growing mycobacteria. This study revealed that reducing protein-mediated outer membrane permeability might constitute a new drug resistance mechanism in slow-growing mycobacteria.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645841      PMCID: PMC4356772          DOI: 10.1128/AAC.04222-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  62 in total

Review 1.  Porins in prokaryotes and eukaryotes: common themes and variations.

Authors:  Kornelius Zeth; Marcus Thein
Journal:  Biochem J       Date:  2010-10-01       Impact factor: 3.857

2.  Bilayer deformation by the Kv channel voltage sensor domain revealed by self-assembly simulations.

Authors:  Peter J Bond; Mark S P Sansom
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

3.  Breaking down the wall: fractionation of mycobacteria.

Authors:  Mandana Rezwan; Marie-Antoinette Lanéelle; Peter Sander; Mamadou Daffé
Journal:  J Microbiol Methods       Date:  2006-07-12       Impact factor: 2.363

4.  Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome.

Authors:  Bibhuti B Mishra; Pedro Moura-Alves; Avinash Sonawane; Nir Hacohen; Gareth Griffiths; Luis F Moita; Elsa Anes
Journal:  Cell Microbiol       Date:  2010-02-09       Impact factor: 3.715

Review 5.  Mycobacterial cell wall: structure and role in natural resistance to antibiotics.

Authors:  V Jarlier; H Nikaido
Journal:  FEMS Microbiol Lett       Date:  1994-10-15       Impact factor: 2.742

6.  Evaluation of Salmonella porins as a broad spectrum vaccine candidate.

Authors:  B Tabaraie; B K Sharma; P R Sharma; R Sehgal; N K Ganguly
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

7.  Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis.

Authors:  K A McDonough; Y Kress
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins.

Authors:  Musa Sani; Edith N G Houben; Jeroen Geurtsen; Jason Pierson; Karin de Punder; Maaike van Zon; Brigitte Wever; Sander R Piersma; Connie R Jiménez; Mamadou Daffé; Ben J Appelmelk; Wilbert Bitter; Nicole van der Wel; Peter J Peters
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

Review 9.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

10.  Release of cytokines induced by Salmonella typhimurium porins.

Authors:  F Galdiero; G C de L'ero; N Benedetto; M Galdiero; M A Tufano
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more
  10 in total

1.  Surface hydrolysis of sphingomyelin by the outer membrane protein Rv0888 supports replication of Mycobacterium tuberculosis in macrophages.

Authors:  Alexander Speer; Jim Sun; Olga Danilchanka; Virginia Meikle; Jennifer L Rowland; Kerstin Walter; Bradford R Buck; Mikhail Pavlenok; Christoph Hölscher; Sabine Ehrt; Michael Niederweis
Journal:  Mol Microbiol       Date:  2015-07-04       Impact factor: 3.501

2.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

Review 3.  Esx Systems and the Mycobacterial Cell Envelope: What's the Connection?

Authors:  Rachel E Bosserman; Patricia A Champion
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

Review 4.  Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope.

Authors:  Mary Jackson; Casey M Stevens; Lei Zhang; Helen I Zgurskaya; Michael Niederweis
Journal:  Chem Rev       Date:  2020-11-10       Impact factor: 60.622

5.  2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.

Authors:  Albert B Jeon; Andrés Obregón-Henao; David F Ackart; Brendan K Podell; Juan M Belardinelli; Mary Jackson; Tuan V Nguyen; Meghan S Blackledge; Roberta J Melander; Christian Melander; Benjamin K Johnson; Robert B Abramovitch; Randall J Basaraba
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

Review 6.  MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis.

Authors:  Geoff Melly; Georgiana E Purdy
Journal:  Microorganisms       Date:  2019-03-05

7.  A FRET-Based Fluorogenic Trehalose Dimycolate Analogue for Probing Mycomembrane-Remodeling Enzymes of Mycobacteria.

Authors:  Nathan J Holmes; Herbert W Kavunja; Yong Yang; B Dillon Vannest; Claudia N Ramsey; Dana M Gepford; Nicholas Banahene; Anne W Poston; Brent F Piligian; Donald R Ronning; Anil K Ojha; Benjamin M Swarts
Journal:  ACS Omega       Date:  2019-02-27

8.  Mycobacterium tuberculosis Toxin CpnT Is an ESX-5 Substrate and Requires Three Type VII Secretion Systems for Intracellular Secretion.

Authors:  B Izquierdo Lafuente; R Ummels; C Kuijl; W Bitter; A Speer
Journal:  mBio       Date:  2021-03-02       Impact factor: 7.867

9.  rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis.

Authors:  Ma-Chao Li; Jie Lu; Yao Lu; Tong-Yang Xiao; Hai-Can Liu; Shi-Qiang Lin; Da Xu; Gui-Lian Li; Xiu-Qin Zhao; Zhi-Guang Liu; Li-Li Zhao; Kang-Lin Wan
Journal:  Infect Drug Resist       Date:  2021-10-05       Impact factor: 4.003

Review 10.  Spatial localization of cathepsins: Implications in immune activation and resolution during infections.

Authors:  Elsa Anes; David Pires; Manoj Mandal; José Miguel Azevedo-Pereira
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.